The World's Premier R&D Innovation Conference for Executives & Biopharma Business Model Innovation
300+ senior leaders from the top 20 pharma companies. 5 themes. 1 focused day. Shaping the future of biopharma business model innovation, R&D, manufacturing, quality, and compliance.
⚠️ Registration closes October 1, 2026. Limited Executive Seats Available (Join 300+ Leaders).
300+ pharmaceutical leaders. 5 focused themes. 1 day that changes how you think about R&D, manufacturing, compliance, and supply chain. Not a conference — a decision room.
"The pharmaceutical industry doesn't need more events. It needs better conversations."
— Pharma Vista Mission Statement
Pharma Vista 2026 is an experiment in what happens when you remove the noise. No vendor pitches, no 500-person auditoriums, no passive webinar scrolling. Just 300 of the sharpest minds in pharmaceutical leadership, convened for a single, focused day of structured dialogue.
Curated by Build Tek Events and backed by an advisory board of pharma veterans, every session is designed to generate insight you can act on Monday morning.
Unpacking how machine intelligence and AI in drug discovery are compressing the drug development timeline. Review the future of pharmaceutical R&D, clinical trial optimisation, and generative chemistry for strategic leadership.
From QC lab modernization AI to cell and gene therapy manufacturing, explore how digital twins, continuous manufacturing, and the biopharma QC lab of the future are delivering real-world ROI on the factory floor.
Navigate FDA 2026 regulatory changes, the ICH-E2B compliance deadline, EU GMP compliance, and GMP inspection best practices. Learn to build inspection-ready cultures under the latest FDA human factors guidance.
The biosimilar boom is reshaping access and competition. Leaders discuss scale-up challenges, analytical characterisation, and market access strategies for global commercial success.
Navigate healthcare investment trends 2026 and pharma market access strategy 2026. Explore China-plus-one strategies, green chemistry mandates, and building resilient API supply chains that withstand global disruptions.
A strategic leadership in pharma session. Naming the tensions: managing patent cliff 2026 revenue risk ($300B revenue loss) and transforming biopharma business model innovation in a complex environment.
Three leaders discuss practical AI in drug discovery. How machine intelligence accelerates the future of pharmaceutical R&D, clinical trials, and pipeline viability.
Real-world implementations of digital twins, IoT, QC lab modernization AI, and cell and gene therapy manufacturing. Accelerating biopharma QC lab of the future outcomes.
A deep dive into FDA 2026 regulatory changes, navigating FDA human factors guidance, EU GMP compliance, and the ICH-E2B compliance deadline. How QA leaders build inspection-ready cultures.
Scale-up science, analytical characterisation challenges, and the commercial strategies that will define the next wave of biopharma growth.
China-plus-one in practice, nearshoring, and green chemistry mandates. Explore healthcare investment trends 2026 and pharma market access strategy 2026 to withstand the legislative cliff 2026.
Recognition of outstanding contributors. The Pharma Vista Inaugural Leadership Awards. A letter from the conveners to the industry.
Structured 1:1 meetings. Themed networking rooms. The conversations that happen after the sessions end.
Virtual-native partnerships — every benefit designed for screen, not physical space. All prices in USD.
Pioneering chemical biologist specializing in macromolecular design and translation. Formulating next-generation platforms for biopharma business model innovation.
Decades of leadership in international drug standard harmonisation. Presenting direct strategies for navigating FDA 2026 regulatory changes and GMP inspection best practices.
Pioneering industrial drug discovery campaigns. Unpacking the implementation of AI in drug discovery to address the $300 billion patent cliff revenue risk.
"Where the Next Decade of Pharma Gets Shaped."
Pharma Vista 2026 is a singular event — invite-only, virtually intimate, and relentlessly focused. If you belong in this room, request your invitation now. Capacity is strictly limited to 300 delegates.
⚠️ Registration closes October 1, 2026. Limited Executive Seats Available.